(J&J recall slideshow updated with company's latest medicine recall)NEW YORK ( TheStreet) -- Medicine recalls that greatly defined Johnson & Johnson ( JNJ) last year continue to pester the company in 2011.
Stocks are narrowly mixed on Friday, putting the S&P 500 and Nasdaq at risk of snapping a six-day winning streak.
The $33 million settlement was announced by the attorney general on behalf of 42 states and the District of Columbia.
Doug Kass shares his thoughts on Treasury notes and bonds, and offers some other observations.
South Korea's Samsung Bioepis is looking to sell its version of the drug in the U.S.